Skip to content
Inciteful Med

Building Your Care Team and Preparing for Visits

Last updated:

Aicardi-Goutières syndrome requires a coordinated team of specialists, including neurologists and immunologists. Parents play a crucial role as project managers by maintaining centralized medical records, bringing imaging disks and lab results to visits, and tracking daily symptoms in a log.

Key Takeaways

  • • A complete AGS care team requires multiple specialists, including neurologists, immunologists, and geneticists, to manage the brain, immune system, and body.
  • • Parents often need to act as the primary project manager, coordinating care across multiple unconnected healthcare systems.
  • • Always bring original genetic reports, MRI imaging disks, and lab results showing the interferon signature to new specialist visits.
  • • Keeping a daily symptom log of fevers, irritability, and skin rashes provides crucial real-world data for your child's doctors.

Because Aicardi-Goutières syndrome (AGS) is a rare, multisystem disease, no single doctor can manage it alone. You will likely find yourself in the role of “Project Manager”—the person who keeps the records, coordinates the specialists, and ensures that everyone is on the same page regarding your child’s care [1][2].

Your Care Team Roster

A complete care team for a child with AGS typically includes a variety of specialists. Each plays a specific role in managing the brain, the immune system, and the body [3][4].

  • Pediatric Neurologist: The “lead” for brain-related symptoms. They manage the neurological aspects like seizures, muscle stiffness (spasticity), and movement disorders (dystonia) [5][6].
  • Medical Geneticist: Crucial for the initial diagnosis. They help interpret genetic reports, explain how the condition was inherited, and discuss risks for future pregnancies [7][8].
  • Immunologist or Rheumatologist: These specialists manage the “interferon storm.” They are usually the ones who prescribe and monitor JAK inhibitors and other immune-modulating treatments [9][10].
  • Gastroenterologist (GI) and Nutritionist: Essential for children who have difficulty swallowing, failure to thrive, or require feeding tubes (G-tubes) [1][11].
  • Palliative Care Specialist: Often misunderstood as “end-of-life” care, palliative care doctors are experts in complex symptom management and improving quality of life for children with serious, chronic conditions [1].
  • Dermatologist: Helpful if your child has severe chilblains or other inflammatory skin rashes [12][13].
  • Therapy Team (PT, OT, Speech/Feeding): Physical, Occupational, and Speech therapists are essential for helping your child maintain mobility, improve comfort, and find safe ways to communicate and swallow [11][14].

Preparing for Your First Specialist Visit

When you see a new specialist, they will need specific data to understand your child’s unique version of AGS. Having these ready will make the visit more productive [15]. It is highly recommended to explicitly ask for physical or digital copies of all clinical visit notes and keep them in a central binder, as you will be navigating multiple unconnected healthcare systems [2].

  1. Genetic Reports: A physical or digital copy of the molecular test that identifies the specific gene mutation (e.g., TREX1 or RNASEH2B) [16].
  2. Imaging Disks: Bring the actual digital images (not just the written report) of any brain MRIs or CT scans [17].
  3. Lab Results: Specifically, look for any tests showing the “interferon signature” or interferon-alpha levels in the blood or spinal fluid [18][3].
  4. The “Symptom Log”: A simple diary of what you see at home—noting when irritability peaks, recording any fever spikes, or taking photos of new skin rashes—provides invaluable “real-world” data for your doctors [11][19].

Managing the “Rare Disease Reality”

In the world of rare diseases, it is common for parents to become the leading experts on their own child’s condition [2]. You may find yourself explaining AGS to ER doctors or school nurses. Don’t be afraid to ask your specialists direct questions to ensure they have the expertise needed to partner with you effectively [20]. Your goal is to build a team that values your observations as a parent and stays current on the latest research and treatments [21][9].

Frequently Asked Questions

What specialists are needed for a child with Aicardi-Goutières syndrome?
A complete AGS care team typically includes a pediatric neurologist, medical geneticist, immunologist or rheumatologist, gastroenterologist, palliative care specialist, dermatologist, and various therapists. Each specialist manages different aspects of the disease, from brain health to the immune system.
What should I bring to my child's first AGS specialist visit?
You should bring physical or digital copies of genetic reports showing the specific gene mutation, imaging disks like brain MRIs, and lab results showing the interferon signature. Additionally, a symptom log documenting daily observations can provide valuable real-world data for the doctor.
How do I manage medical records for a rare disease like AGS?
Because you will be navigating multiple unconnected healthcare systems, parents often act as the project manager. It is highly recommended to explicitly ask for copies of all clinical visit notes, lab results, and imaging disks to keep in a central physical or digital binder.
Which doctor prescribes JAK inhibitors for Aicardi-Goutières syndrome?
JAK inhibitors and other immune-modulating treatments for AGS are typically prescribed and monitored by an immunologist or a rheumatologist. They specialize in managing the interferon storm associated with the condition.
Why might my child with AGS need a gastroenterologist?
A gastroenterologist and nutritionist are essential for children with AGS who experience difficulty swallowing, failure to thrive, or require feeding tubes to ensure they receive proper nutrition safely.

Questions for Your Doctor

  • • How many other patients with Aicardi-Goutières syndrome have you managed in your career?
  • • Are you familiar with the most recent consensus guidelines for monitoring and treating type I interferonopathies?
  • • What is your protocol for monitoring a child on JAK inhibitors—how often do you check the interferon score and blood counts?
  • • If we encounter a system-wide issue, like a new skin rash or a change in liver enzymes, who on the team should be our first point of contact?
  • • Given our child's genetic subtype, do we need to schedule a consultation with a GI specialist or nutritionist?

Questions for You

  • • Have you designated one person in your family to be the 'lead' for keeping medical records and scheduling appointments?
  • • Do you have a reliable way to transport MRI disks and paper reports between different hospitals and specialists?
  • • What is your preferred method of communication (e.g., patient portal, email, or phone) for reaching your care team when you have a question?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Experiences and Hope in Caregivers of Children With Aicardi Goutières Syndrome.

    Gavazzi F, Martin A, Sevagamoorthy A, et al.

    Journal of child neurology 2025; (40(7)):543-554 doi:10.1177/08830738251341530.

    PMID: 40400365
  2. 2

    A novel patient-Centered approach to clinical trial readiness in rare diseases: Application in Aicardi-Goutières Syndrome (AGS).

    Sevagamoorthy A, Gavazzi F, Tashnim Z, et al.

    Molecular genetics and metabolism 2026; (147(3)):109765 doi:10.1016/j.ymgme.2026.109765.

    PMID: 41671914
  3. 3

    Aicardi-Goutières syndrome: A monogenic type I interferonopathy.

    Liu A, Ying S

    Scandinavian journal of immunology 2023; (98(4)):e13314 doi:10.1111/sji.13314.

    PMID: 37515439
  4. 4

    Talents Amidst Neurological Impairment; an Interesting Case of Aicardi-Goutières Syndrome.

    Tabibi P, Shiari R, Sharafian S, Shiari S

    Clinical case reports 2025; (13(5)):e70530 doi:10.1002/ccr3.70530.

    PMID: 40415876
  5. 5

    Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients.

    Al Mutairi F, Alfadhel M, Nashabat M, et al.

    Pediatric neurology 2018; (78()):35-40 doi:10.1016/j.pediatrneurol.2017.09.002.

    PMID: 29239743
  6. 6

    Neurological Findings and a Brief Review of the Current Literature in a Severe Case of Aicardi-Goutières Syndrome Due to an IFIH1 Mutation.

    Železnik M, Vesnaver TV, Neubauer D, Soltirovska-Šalamon A

    Neuropediatrics 2024; (55(5)):337-340 doi:10.1055/a-2321-0597.

    PMID: 38714209
  7. 7

    An overview of genetic mutations in Aicardi-Goutières syndrome in Iranian population.

    Khalilian S, Fathi M, Miryounesi M, Ghafouri-Fard S

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(2)):999-1007 doi:10.1007/s10072-024-07824-x.

    PMID: 39470906
  8. 8

    The c.529G>A (p.Ala177Thr) RNASEH2B Gene Pathogenic Variant as a First-Line Genetic Test for Aicardi-Goutières Syndrome: A Case Series of Four Moroccan Families.

    Ouhenach M, Nada A, Lyahyai J, Sefiani A

    American journal of medical genetics. Part A 2025; (197(6)):e63997 doi:10.1002/ajmg.a.63997.

    PMID: 39890436
  9. 9

    Exploring emerging JAK inhibitors in the treatment of Aicardi-Goutières syndrome.

    Politano D, Tonduti D, Battini R, et al.

    Expert opinion on emerging drugs 2024; 1-19 doi:10.1080/14728214.2024.2445508.

    PMID: 39704072
  10. 10

    Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutières syndrome.

    Galli J, Cattalini M, Loi E, et al.

    Clinical case reports 2023; (11(8)):e7724 doi:10.1002/ccr3.7724.

    PMID: 37534202
  11. 11

    Developmental Outcomes of Aicardi Goutières Syndrome.

    Adang L, Gavazzi F, De Simone M, et al.

    Journal of child neurology 2020; (35(1)):7-16 doi:10.1177/0883073819870944.

    PMID: 31559893
  12. 12

    Dyschromatosis symmetrica hereditaria: A clue to early diagnosis of Aicardi-Goutières syndrome.

    Ahmed F, Do N, Vanderver AL, Treat JR

    Pediatric dermatology 2024; (41(1)):156-157 doi:10.1111/pde.15437.

    PMID: 37770123
  13. 13

    Short-term efficacy of tofacitinib, a JAK inhibitor, in IFIH1-related Aicardi-Goutières syndrome.

    Hou L, Zhou P, Du Y, et al.

    European journal of medical genetics 2025; (75()):105006 doi:10.1016/j.ejmg.2025.105006.

    PMID: 40043752
  14. 14

    Exploration of Gross Motor Function in Aicardi-Goutières Syndrome.

    Gavazzi F, Glanzman AM, Woidill S, et al.

    Journal of child neurology 2023; (38(8-9)):518-527 doi:10.1177/08830738231188753.

    PMID: 37499181
  15. 15

    PNPT1 mutations may cause Aicardi-Goutières-Syndrome.

    Bamborschke D, Kreutzer M, Koy A, et al.

    Brain & development 2021; (43(2)):320-324 doi:10.1016/j.braindev.2020.10.005.

    PMID: 33158637
  16. 16

    The prototypical interferonopathy: Aicardi-Goutières syndrome from bedside to bench.

    Hofer MJ, Modesti N, Coufal NG, et al.

    Immunological reviews 2024; (327(1)):83-99 doi:10.1111/imr.13413.

    PMID: 39473130
  17. 17

    Clinical and neuroradiologic variability of Aicardi-Goutiéres syndrome: Two siblings with RNASEH2C mutation and a boy with TREX1 mutation.

    Uyur Yalçın E, Maraş Genç H, Kara B

    The Turkish journal of pediatrics 2015; (57(5)):504-8.

    PMID: 27411419
  18. 18

    Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis.

    Galli J, Gavazzi F, De Simone M, et al.

    Medicine 2018; (97(52)):e13893 doi:10.1097/MD.0000000000013893.

    PMID: 30593198
  19. 19

    Multiple Autoimmune Disorders in Aicardi-Goutières Syndrome.

    Samanta D, Ramakrishnaiah R, Crary SE, et al.

    Pediatric neurology 2019; (96()):37-39 doi:10.1016/j.pediatrneurol.2019.01.017.

    PMID: 30898416
  20. 20

    The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.

    Cetin Gedik K, Lamot L, Romano M, et al.

    Annals of the rheumatic diseases 2022; (81(5)):601-613 doi:10.1136/annrheumdis-2021-221814.

    PMID: 35086813
  21. 21

    Delayed Diagnosis of Aicardi-Goutières Syndrome in a 10-Year-Old Female Child With TREX1 Mutation: A Case Report.

    Al Zayer L, Al Zayer M, Alrujaib A, et al.

    Cureus 2025; (17(2)):e79730 doi:10.7759/cureus.79730.

    PMID: 40161088

This page is for educational purposes only and does not replace professional medical advice. Always consult your child's healthcare team regarding specific Aicardi-Goutières syndrome treatments and care coordination.

Stay up to date

Get notified when new research about Aicardi-Goutières syndrome is published.

No spam. Unsubscribe anytime.